Nothing Special   »   [go: up one dir, main page]

AU4429100A - The process for manufacturing topical ophthalmic preparations without systemic effects - Google Patents

The process for manufacturing topical ophthalmic preparations without systemic effects

Info

Publication number
AU4429100A
AU4429100A AU44291/00A AU4429100A AU4429100A AU 4429100 A AU4429100 A AU 4429100A AU 44291/00 A AU44291/00 A AU 44291/00A AU 4429100 A AU4429100 A AU 4429100A AU 4429100 A AU4429100 A AU 4429100A
Authority
AU
Australia
Prior art keywords
systemic effects
topical ophthalmic
ophthalmic preparations
manufacturing topical
manufacturing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU44291/00A
Other languages
English (en)
Inventor
Bakulesh Mafatlal Khamar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU4429100A publication Critical patent/AU4429100A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU44291/00A 1999-02-03 2000-02-02 The process for manufacturing topical ophthalmic preparations without systemic effects Abandoned AU4429100A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN90/BOM/99 1999-02-03
IN90BO1999 IN185228B (fr) 1999-02-03 1999-02-03
PCT/IN2000/000008 WO2000049990A2 (fr) 1999-02-03 2000-02-02 Procede de production de preparations ophtalmiques a usage local sans effet systemique

Publications (1)

Publication Number Publication Date
AU4429100A true AU4429100A (en) 2000-09-14

Family

ID=11077485

Family Applications (1)

Application Number Title Priority Date Filing Date
AU44291/00A Abandoned AU4429100A (en) 1999-02-03 2000-02-02 The process for manufacturing topical ophthalmic preparations without systemic effects

Country Status (11)

Country Link
EP (1) EP1139970A2 (fr)
AP (1) AP2000001977A0 (fr)
AU (1) AU4429100A (fr)
BR (1) BR0004530A (fr)
CA (1) CA2326690A1 (fr)
EA (1) EA200000918A1 (fr)
ID (1) ID28121A (fr)
IL (1) IL138824A0 (fr)
IN (1) IN185228B (fr)
WO (1) WO2000049990A2 (fr)
ZA (1) ZA200006252B (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001273269B2 (en) * 2000-07-14 2005-08-11 Allergan, Inc. Compositions containing alpha-2-adrenergic agonist components
AU2005220199B2 (en) * 2000-07-14 2007-03-08 Allergan, Inc. Compositions containing alpha-2-adrenergic agonist components

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8858961B2 (en) 2000-07-14 2014-10-14 Allergan, Inc. Compositions containing alpha-2-adrenergic agonist components
DE10132876A1 (de) * 2001-07-06 2003-01-30 Medproject Pharma Entwicklungs Zweiphasige, tropfbare Hydrogele zur Anwendung am Auge
US7439241B2 (en) 2003-05-27 2008-10-21 Galderma Laboratories, Inc. Compounds, formulations, and methods for treating or preventing rosacea
PT1761266E (pt) 2004-05-25 2013-06-04 Galderma Pharma Sa Compostos, formulações, e métodos para tratamento ou prevenção de distúrbios inflamatórios da pele
EP2329849B1 (fr) 2009-11-18 2015-04-29 Galderma Research & Development Combinaison d'un agoniste du récepteur alpha-2 adrénergique et d'un agent anti-inflammatoire non stéroïdien pour traiter ou empêcher un trouble cutané inflammatoire
FR2977493B1 (fr) 2011-07-05 2014-02-14 Galderma Res & Dev Nouvelle composition anesthesique stable pour la reduction des reactions cutanees
AU2014216112B2 (en) 2013-02-15 2019-02-21 Allergan, Inc. Sustained drug delivery implant
WO2014150899A1 (fr) * 2013-03-15 2014-09-25 Chapin Matthew J Formulations ophtalmiques topiques pour traiter la migraine
US9421199B2 (en) 2014-06-24 2016-08-23 Sydnexis, Inc. Ophthalmic composition
WO2016172712A2 (fr) 2015-04-23 2016-10-27 Sydnexis, Inc. Composition ophtalmique
US11382909B2 (en) 2014-09-05 2022-07-12 Sydnexis, Inc. Ophthalmic composition
EP3302426A4 (fr) 2015-05-29 2018-12-05 Sydnexis, Inc. Formulations pharmaceutiques stabilisées de d2o
GB202110420D0 (en) * 2021-07-20 2021-09-01 Rosemont Pharmaceuticals Ltd Liquid pharmaceutical composition of clonidine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6056684B2 (ja) * 1977-11-07 1985-12-11 東興薬品工業株式会社 点眼剤
DD294174A5 (de) * 1990-05-04 1991-09-26 Sigrid Keipert Ophthalmika mit retardwirkung und ein neues verfahren zu ihrer herstellung
FR2678832B1 (fr) * 1991-07-10 1995-03-17 Europhta Sa Laboratoire Nouvelles compositions ophtalmiques a resorption amelioree et leurs procedes de preparation.
FR2679773A1 (fr) * 1991-07-30 1993-02-05 Merck Sharp & Dohme Preparation ophtalmique contenant un agent osmotique acceptable antimicrobien.
DE19614823A1 (de) * 1996-04-15 1997-10-16 Mann Gerhard Chem Pharm Fab Ophthalmische Zusammensetzung mit verlängerter Verweilzeit am Auge

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001273269B2 (en) * 2000-07-14 2005-08-11 Allergan, Inc. Compositions containing alpha-2-adrenergic agonist components
AU2005220199B2 (en) * 2000-07-14 2007-03-08 Allergan, Inc. Compositions containing alpha-2-adrenergic agonist components

Also Published As

Publication number Publication date
EP1139970A2 (fr) 2001-10-10
IL138824A0 (en) 2001-10-31
ID28121A (id) 2001-05-03
WO2000049990A2 (fr) 2000-08-31
BR0004530A (pt) 2001-04-03
WO2000049990A3 (fr) 2001-07-26
ZA200006252B (en) 2001-11-29
IN185228B (fr) 2000-12-09
AP2000001977A0 (en) 2000-12-31
EA200000918A1 (ru) 2001-10-22
CA2326690A1 (fr) 2000-08-31

Similar Documents

Publication Publication Date Title
AU4211600A (en) Modified lipid production
AU7859800A (en) Topical nasal treatment
AU4429100A (en) The process for manufacturing topical ophthalmic preparations without systemic effects
AU2002245115A1 (en) Monolithic part and process for making the same
AU5482700A (en) On-line savings model
AU4905499A (en) Topical aciclovir formulations
AU2001267831A1 (en) DDS compound and process for the preparation thereof
AU5651799A (en) Remedies for photochemotherapy
AU3285700A (en) Workbench
AU2001263835A1 (en) Haemostatically active preparation containing vWF and method for the production thereof
AU1538901A (en) Polymersation process
AU4090299A (en) Liposomal delivery complex
AU4396900A (en) Flouring process
AU2001252671A1 (en) Pyridobenzodiazine derivatives and processes for the preparation thereof
AU2001266031A1 (en) Process for drying amoxicillin
AU2943400A (en) Process for the preparation of alpha-aminoketone derivatives
AU1151501A (en) Stud for tire
AU4508101A (en) Lipid nanotubules for topical delivery
AU1091901A (en) Shopping advisor component
AU2829700A (en) Processes for the preparation of alpha-aminoketones
AU6870500A (en) Process for the preparation of 2,3-dihydroazepine derivatives
AU3624400A (en) Chromatographic albumin process
AU2001252254A1 (en) 2,6-diamino-6-methyl-heptanoic acid and derivatives, process for the preparationthereof and use thereof
AU3837100A (en) Vitamin d derivatives and process for producing the same
AU4504201A (en) Drug preparations

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase